Molecular Templates (MTEM) Competitor Comparison
We are evaluating the key criteria listed to compare Molecular Templates (MTEM) against its competitors in the Biotechnology industry.
Market Capitalization
324 / 368Gross Profits
0 / 278Total Revenue
117 / 300EBITDA
78 / 337Free Cashflow
174 / 352Quick Ratio
338 / 357Earnings per Share
254 / 359Dividend yield
0 / 6Total Cash
308 / 358Performance 3 years
358 / 368Performance 5 years
352 / 368Performance 10 years
345 / 368Linearity 3 years
321 / 368Linearity 5 years
185 / 368Linearity 10 years
252 / 368Total Rank
337 / 368Dividend Rank
210 / 368Valuation Rank
150 / 368Piotroski Rank
335 / 368Muliplier Rank
160 / 368Market Capitalization - MTEM ranking 324 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.